Results support the potential of the antibody-functionalized ESDI platform for label-free detection of CD44-expressing cells, providing a groundwork for its validation in clinical samples as a step toward tumor-cell diagnostics.
Graphene oxide-coated semi-distributed interferometric biosensor is established as a highly sensitive platform for CD44 detection in clinically relevant samples and its potential for future development toward the detection of other circulating biomarkers is highlighted.
K. Seitkamal, A. Bekmurzayeva, Kanagat Kantoreyeva et al.· ACS Sensors· 0 citations
In this work, a compact dual-parameter fiber optic sensor for temperature, refractive index, and label-free biomarker-related measurements is presented. The sensor is based on a chirped fiber Bragg grating cleaved inside the grating region, leaving residual grating lengths of 3 mm, 4 mm, and 5 mm. After cleaving, the r...
Shakhrizat Alisherov, Aidana Bekenkali, Sabina Sairangazy et al.· Italian National Conference...· 0 citations
Introduction: The study of triple-negative breast cancer cells detection is one of the important research fields in modern biomedical engineering, due to its aggressive behavior and limited targeting options. One of the promising methods for cancer cell detection is using Molecularly Imprinted Polymers (MIPs) with poly...
Bakdaulet Yendibay, Akmaral Suleimenova, Aigerim Omirzakova et al.· Oncology, Nuclear Medicine a...· 0 citations
The developed fiber-optic biosensors show potential for integration into liquid biopsy platforms for label-free detection of circulating tumor cells in biological fluids, providing a rapid and minimally invasive approach for cancer detection and monitoring.
Aigerim Omirzakova, Lyazzat Mukhangaliyeva, Marzhan Nurlankyzy et al.· Oncology, Nuclear Medicine a...· 0 citations
The development of a graphene oxide-coated fiber-optic biosensor based on a semi-distributed interferometric sensing platform for the highly sensitive detection of solCD44, a cell adhesion glycoprotein whose soluble form is elevated in several cancers including breast cancer, is reported.
K. Seitkamal, A. Bekmurzayeva, A. Aubakirova et al.· Oncology, Nuclear Medicine a...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.